Incidence of Infections and Predictors of Mortality During Checkpoint Inhibitor Immunotherapy in Patients With Advanced Lung Cancer: A Retrospective Cohort Study

BACKGROUND: Immune checkpoint inhibitors (ICIs) have revolutionized nonsmall cell lung cancer (NSCLC) treatment and significantly increased overall survival of patients. However, the incidence of concurrent infections and their management is still debated. METHODS: From August 2015 to October 2019,...

Descripción completa

Detalles Bibliográficos
Autores principales: Bavaro, Davide Fiore, Pizzutilo, Pamela, Catino, Annamaria, Signorile, Fabio, Pesola, Francesco, Di Gennaro, Francesco, Cassiano, Sandro, Marech, Ilaria, Lamorgese, Vito, Angarano, Gioacchino, Monno, Laura, Saracino, Annalisa, Galetta, Domenico
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Major Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8204890/
https://www.ncbi.nlm.nih.gov/pubmed/34141817
http://dx.doi.org/10.1093/ofid/ofab187

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8204890/
https://www.ncbi.nlm.nih.gov/pubmed/34141817
http://dx.doi.org/10.1093/ofid/ofab187

Ejemplares similares